Björnsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology. 2005;42:481–9.

Article  PubMed  Google Scholar 

Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, et al. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology. 2015;148:1340-52.e7.

Article  PubMed  Google Scholar 

Stephens C, Robles-Diaz M, Medina-Caliz I, Garcia-Cortes M, Ortega-Alonso A, Sanabria-Cabrera J, et al. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry. J Hepatol. 2021;75:86–97.

Article  PubMed  CAS  Google Scholar 

Björnsson ES, Bergmann OM, Björnsson HK, Kvaran R, Olafsson S. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology. 2013;144:1419–25.

Article  PubMed  Google Scholar 

Bessone F, Hernandez N, Mendizabal M, Sanchez A, Paraná R, Arrese M, et al. When the creation of a consortium provides useful answers: experience of the Latin American DILI network (LATINDILIN). Clin Liver Dis (Hoboken). 2019;13:51–7.

Article  PubMed  Google Scholar 

Devarbhavi H, Joseph T, Sunil Kumar N, Rathi C, Thomas V, Singh SP, et al. The indian network of drug-induced liver injury: etiology, clinical features, outcome and prognostic markers in 1288 patients. J Clin Exp Hepatol. 2021;11:288–98.

Article  PubMed  CAS  Google Scholar 

Björnsson ES, Stephens C, Atallah E, Robles-Diaz M, Alvarez-Alvarez I, Gerbes A, et al. A new framework for advancing in drug-induced liver injury research. The Prospective European DILI Registry. Liver Int. 2023;43:115–26.

Article  PubMed  Google Scholar 

Björnsson B, Bergqvist A, Jerlstad P, Olsson R. Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden. Scand J Gastroenterol. 2005;40:1095–101.

Article  PubMed  Google Scholar 

Reuben A, Koch DG, Lee WM. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology. 2010;52:2065–76.

Article  PubMed  Google Scholar 

Wei G, Bergquist A, Broome U, Lindgren S, Wallerstedt S, Almer S, Sangfeldt P, et al. Acute liver failure in Sweden: etiology and outcome. J Intern Med. 2007;262:392–401.

Article  Google Scholar 

Björnsson ES, Hoofnagle JH. Categorization of drugs implicated in causing liver injury: critical assessment based upon published case reports. Hepatology. 2016;63:590–603.

Article  PubMed  Google Scholar 

de Abajo FJ, Montero D, Madurga M, Garcia Rodrigues LA. Acute and clinically relevant drug-induced liver injury: a population based case-control study. Br J Clin Pharmacol. 2004;58:71–80.

Article  PubMed  PubMed Central  Google Scholar 

Suzuki A, Tillmann H, Williams J, Hauser RG, Frund J, Suzuki M, et al. Assessment of the frequency, phenotypes, and outcomes of acute liver injury associated with amoxicillin/clavulanate in 1.4 million patients in the Veterans Health Administration. Drug Saf. 2023;46:129–43.

Article  PubMed  CAS  Google Scholar 

Kang Y, Kim S-H, Park SY, Park BY, Lee JH, An J, et al. Evaluation of drug-induced liver injury developed during hospitalization using electronic health record (HER)-based algorithm. Allergy Asthma Immunol Res. 2020;12:430–42.

Article  PubMed  PubMed Central  CAS  Google Scholar 

https://www.ncbi.nlm.nih.gov/books/NBK547852/

Alqahtani SA, Kleiner DE, Ghabril M, Gu J, Hoofnagle JH, Rockey DC. Identification and characterization of cefazolin-induced liver injury. Dig Dis Sci. 2016;61:2406–16.

Google Scholar 

Aithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, et al. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther. 2011;89:806–15.

Article  PubMed  CAS  Google Scholar 

Hayashi PH, Lucena MI, Fontana RJ, Bjornsson ES, Aithal GP, Barnhart H, et al. A revised electronic version of RUCAM for the diagnosis of drug induced liver injury. Hepatology. 2022;76:18–31.

Article  PubMed  CAS  Google Scholar 

De Valle MB, Av Klinteberg V, Alem N, Olsson R, Björnsson E. Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic. Aliment Pharmacol Ther. 2006;24:1187–95.

Article  PubMed  Google Scholar 

Sgro C, Clinard F, Ouazir K, Chanay H, Allard C, Guilleminet C, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology. 2002;36:451–5.

Article  PubMed  Google Scholar 

Shin J, Hunt CM, Suzuki A, Papay JI, Beach KJ, Cheetham TC. Characterizing phenotypes and outcomes of drug-associated liver injury using electronic medical record data. Pharmacoepidemiol Drug Saf. 2013;22:190–8.

Article  PubMed  Google Scholar 

Chen VL, Rockey DC, Bjornsson ES, Barnhart H, Hoofnagle JH. Incidence of idiosyncratic drug-induced liver injury caused by prescription drugs. Drug Saf. 2024;48:151–60.

Article  PubMed  Google Scholar 

Kwon H, Lee SH, Kim SE, Lee JH, Jee YK, Kang HR, et al. Spontaneously reported hepatic adverse drug events in Korea: multicenter study. J Korean Med Sci. 2012;27:268–73.

Article  PubMed  PubMed Central  Google Scholar 

Pedraza L, Laosa O, Rodríguez-Mañas L, et al. Drug induced liver injury in geriatric patients detected by a two-hospital prospective pharmacovigilance program: a comprehensive analysis using the Roussel Uclaf causality assessment method. Front Pharmacol. 2020;11: 600255.

Article  PubMed  CAS  Google Scholar 

Cabanas R, Calderon O, Ramirez E, Fiandor A, Prior N, Caballero T, et al. Piperacillin-induced DRESS: distinguishing features observed in a clinical and allergy study of 8 patients. J Investig Allergol Clin Immunol. 2014;24:425–30.

PubMed  CAS  Google Scholar 

Rao A, Rule JA, Hameed B, Ganger D, Fontana RJ, Lee WM. Secular trends in severe idiosyncratic drug-induced liver injury in North America: an update from the acute liver failure study group registry. Am J Gastroenterol. 2022;117:617–26.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gekhman D, Correa E. One DOSE of cefazolin—months of misery: a case of acute liver failure with grave consequences: 3039. Am J Gastroenterol. 2018;113:S1664–5.

Article  Google Scholar 

deLemos AS, Ghabril M, Rockey DC, Gu J, Barnhart H, Fontana RJ, et al. Amoxicillin-clavulanate-induced liver injury. Dig Dis Sci. 2016;61:2406–16.

Article  PubMed  PubMed Central  CAS  Google Scholar